News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eleven Biotherapeutics Appoints Eric Furfine, Ph.D., to President of Research and Development



1/6/2011 8:58:35 AM

(BUSINESS WIRE)--Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, today announced the appointment of Eric Furfine, Ph.D., as president of research and development. Dr. Furfine replaces Burt Adelman, M.D., who has served as the company’s interim president of research and development since its founding. Dr. Adelman will continue to serve as a scientific advisor to the company.

Read at Business Wire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES